Trial intelligence / Profile preview

Intradialytic Vasopressin for BP Control in ESRD

NCT01247090Phase 2Completed

Sponsor
Columbia University
Start
Oct 2010
Primary completion
Aug 2018
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of vasopressin in hypertension (HTN), sponsored by Columbia University. Started Oct 2010; status: completed.

02

Drugs

vasopressin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01247090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01247090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call